Using a propensity-matched cohort of 322 patients (161 in each group: cCR vs. no cCR), Mbanu et al. identified pre-treatment tumor diameter, tumor stage on magnetic resonance imaging (MRI), hemoglobin, alkaline phosphate, total radiotherapy depths, neutrophil-to-lymphocyte ratio (NLR), neutrophil-monocyte-to-lymphocyte ratio (NMLR), lymphocyte count, and albumin level as significant predictors of cCR [36]. Here, ALB is linked to neoplasm.